Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Significance of resection margin as a risk factor for local control of early stage breast cancer

J. Gatek, D. Vrana, L. Lukesova, M. Pospiskova, P. Vazan, B. Melichar

. 2013 ; 157 (3) : 209-213.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc14049947

INTRODUCTION: Breast conserving surgery combined with sentinel node biopsy represents currently the gold standard of treatment for early breast cancer. Although breast conserving surgery has been a widely accepted method for many years, there remain some highly controversial unresolved issues. The present analysis focused on the resection margin as one of the key factors for local control of the disease. METHODS: Patient disease free survival and overall survival were collected from patients undergoing breast conserving surgery from 2004 to 2009 at the Department of Surgery Atlas hospital Zlin, Czech Republic. All patients with resection margin less then 5 mm were re-resected to achieve this clear resection margin of 5mm or more. Disease free survival (more specifically local relapse free survival, metastasis free survival and regional free survival) and overall survival were assessed. RESULTS: The data on 330 patients were analyzed and 286/330 cases had complete follow-up. After a median follow-up of 70 months, 7 patients with isolated local relapse were identified (2.44%), 13 patients with distant metastasis without local relapse (4.54%) and 2 patients with relapse in the axilla without local relapse in the breast (0.7%). CONCLUSION: The final decision about the extent of resection margin remains controversial but based on the data on local control presented here it seems reasonable to increase the criteria for a clear resection margin to 5 mm.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14049947
003      
CZ-PrNML
005      
20140328105930.0
007      
ta
008      
140325s2013 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2013.067 $2 doi
035    __
$a (PubMed)24042334
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gatěk, Jiří, $d 1950- $7 xx0052958 $u Department of Surgery, Atlas Hospital, Tomas Bata University in Zlin, Zlin
245    10
$a Significance of resection margin as a risk factor for local control of early stage breast cancer / $c J. Gatek, D. Vrana, L. Lukesova, M. Pospiskova, P. Vazan, B. Melichar
520    9_
$a INTRODUCTION: Breast conserving surgery combined with sentinel node biopsy represents currently the gold standard of treatment for early breast cancer. Although breast conserving surgery has been a widely accepted method for many years, there remain some highly controversial unresolved issues. The present analysis focused on the resection margin as one of the key factors for local control of the disease. METHODS: Patient disease free survival and overall survival were collected from patients undergoing breast conserving surgery from 2004 to 2009 at the Department of Surgery Atlas hospital Zlin, Czech Republic. All patients with resection margin less then 5 mm were re-resected to achieve this clear resection margin of 5mm or more. Disease free survival (more specifically local relapse free survival, metastasis free survival and regional free survival) and overall survival were assessed. RESULTS: The data on 330 patients were analyzed and 286/330 cases had complete follow-up. After a median follow-up of 70 months, 7 patients with isolated local relapse were identified (2.44%), 13 patients with distant metastasis without local relapse (4.54%) and 2 patients with relapse in the axilla without local relapse in the breast (0.7%). CONCLUSION: The final decision about the extent of resection margin remains controversial but based on the data on local control presented here it seems reasonable to increase the criteria for a clear resection margin to 5 mm.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádory prsu $x patologie $x radioterapie $x chirurgie $7 D001943
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a segmentální mastektomie $x metody $7 D015412
650    _2
$a lidé středního věku $7 D008875
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a lokální recidiva nádoru $x radioterapie $7 D009364
650    _2
$a adjuvantní radioterapie $7 D018714
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a biopsie sentinelové lymfatické uzliny $7 D021701
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vrána, David $7 xx0103187
700    1_
$a Lukešová, Lucie $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc $7 xx0234590
700    1_
$a Pospíšková, Markéta $u Department of Oncology, Bata Hospital Zlin, Zlin $7 xx0229118
700    1_
$a Vážan, Petr $u Cytologic and Histopathologic Laboratory, Zlin $7 xx0143266
700    1_
$a Melichar, Bohuslav, $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc $d 1965- $7 skuk0000853
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 3 (2013), s. 209-213
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20140325 $b ABA008
991    __
$a 20140327094704 $b ABA008
999    __
$a ok $b bmc $g 1017419 $s 848517
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 157 $c 3 $d 209-213 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20140325

Find record

Citation metrics

Archiving options